Labormed Alvogen isi reevalueaza, in vederea delistarii, portofoliul de medicamente cu pretul de sub 10 lei
Labormed Pharma, companie a grupului american Alvogen, a anuntat marti ca a demarat procesul de reevaluare a intregului portofoliu de medicamente, intentia fiind de a delista de pe lista medicamentelor compensate produsele fabricate al caror pret de producator este sub 10 lei.
:format(webp):quality(80)/https://www.dailybusiness.ro/wp-content/uploads/2015/02/54da293575977.jpg)
:format(webp):quality(80)/https://www.dailybusiness.ro/wp-content/themes/strawberry-daily-202207/assets/images/avatar.png){kind=avatar}
Trending
:format(webp):quality(80)/https://www.dailybusiness.ro/wp-content/uploads/2024/02/Noua-Lege-a-pensiilor-Marius-Budai.jpg)
:format(webp):quality(80)/https://www.dailybusiness.ro/wp-content/uploads/2024/02/salariul-minim-european.jpg)
19 Feb. - 19:12
:format(webp):quality(80)/https://www.dailybusiness.ro/wp-content/uploads/2024/01/pensii-10.jpg)
19 Feb. - 17:05
:format(webp):quality(80)/https://www.dailybusiness.ro/wp-content/uploads/2024/02/LEGEA-PENSIILOR-simona-bucura-oprescu-diana-daily.jpg)
:format(webp):quality(80)/https://www.dailybusiness.ro/wp-content/uploads/2024/02/coada-Casa-de-Pensii-1.jpg)
20 Feb. - 12:17